Prostate Cancer



How do we diagnose Prostate Cancer?

Magnetic Resonance (MR):
MR is a very powerful tool for diagnosing prostate cancer.  MR uses a powerful magnetic field to produce detailed images of the prostate gland. MRI does not use or produce radiation and is not associated with radiation risks or effects.
For more information on Prostate MRI please see

Bone Scan:
A bone scan is a very accurate test to detect any disease in the bones.  Prostate cancer can commonly spread to the bone (metastasize) where they absorb a greater amount of the radiotracer than normal bone.
For more information on Bone Scans please see

CT Scan:
CT scan is one of the most common ways to follow prostate cancer and detect spread (metastases). CT scanners use a series of x-rays and powerful computers to create 2 and 3-dimensional images of the body.
For more information on CT scans please see

PET/CT is an advanced method that can detect the spread (metastases) of prostate cancer. In cases of prostate cancer a special radio tracer, fluciclovine F-18, also known as Axumin is used conjunction with a CT scan to show sites of disease. This technique is much more sensitive for finding metastases than CT alone.
For more information on PET/CTCT please see

How do we treat Prostate Cancer?

Prostate cancer is usually treated by a multidisciplinary team of physicians.  Radiologists treat bone metastases from prostate cancer
with a noninvasive technique called Xofigo (radium 223 dichloride). This compound is taken up by bone cells and kills metastatic prostate cancer cells with a small targeted dose of radiation without damaging normal nearby cells. The goal of this treatment is to target the metastases while avoiding the whole-body effects of radiation therapy or chemotherapy.